Published in Lancet Oncol on January 01, 2006
Pseudomyxoma peritonei. World J Gastrointest Oncol (2010) 1.76
Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis. Case Rep Oncol Med (2016) 1.44
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol (2009) 1.34
A new standard of care for the management of peritoneal surface malignancy. Curr Oncol (2011) 1.20
Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol (2011) 1.18
Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence. Nat Rev Clin Oncol (2009) 1.13
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei. Br J Cancer (2008) 1.13
Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. Ann Surg Oncol (2012) 1.12
Multicystic peritoneal mesothelioma. Am J Case Rep (2012) 1.06
Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Gastrointest Oncol (2010) 1.05
Appendiceal mucocoeles and pseudomyxoma peritonei. World J Gastroenterol (2007) 1.04
FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. Oncologist (2014) 1.00
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei. Br J Cancer (2006) 0.99
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am Coll Surg (2012) 0.96
A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial. BMC Cancer (2013) 0.96
Pseudomyxoma peritonei: a need to establish evidence-based standard of care--is this the right trial? Ann Surg Oncol (2009) 0.95
GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer (2014) 0.95
Comparative analysis of perioperative intraperitoneal chemotherapy regimen in appendiceal and colorectal peritoneal carcinomatosis. Int J Clin Oncol (2012) 0.93
Malignant peritoneal mesothelioma. World J Gastrointest Surg (2009) 0.92
Surgery for perforated colorectal malignancy in an Asian population: an institution's experience over 5 years. Int J Colorectal Dis (2010) 0.92
Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. Cancer Imaging (2013) 0.92
Peritoneal carcinosis of ovarian origin. World J Gastrointest Oncol (2010) 0.89
Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist (2013) 0.89
Primary appendiceal mucinous adenocarcinoma alongside with situs inversus totalis: a unique clinical case. World J Surg Oncol (2010) 0.88
Mucinous adenocarcinomas with intra-abdominal dissemination: a review of current therapy. Oncologist (2010) 0.88
Clinicopathological analysis of primary epithelial appendiceal neoplasms. Med Oncol (2009) 0.87
Hyperthermic intraperitoneal chemoperfusion (HIPEC) decrease wound strength of colonic anastomosis in a rat model. Int J Colorectal Dis (2007) 0.85
Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience. World J Gastrointest Surg (2012) 0.85
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. Gastroenterol Res Pract (2012) 0.85
Management of appendiceal pseudomyxoma peritonei diagnosed during pregnancy. World J Surg Oncol (2009) 0.85
Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis (2011) 0.85
Perforated tumours in the gastrointestinal tract: CT findings and clinical implications. Br J Radiol (2012) 0.84
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis. J Control Release (2015) 0.83
Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis. Ann Surg Oncol (2013) 0.83
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis. BMC Cancer (2014) 0.83
Risk-reducing laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for low-grade appendiceal mucinous neoplasm: early outcomes and technique. Surg Endosc (2013) 0.82
Cytoreductive surgery plus hyperthermic perioperative chemotherapy for selected patients with peritoneal metastases from colorectal cancer: a new standard of care or an experimental approach? Gastroenterol Res Pract (2012) 0.81
Four mucinous cystadenoma of the appendix treated by different approaches. Ulus Cerrahi Derg (2014) 0.81
Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix. Can J Surg (2009) 0.81
Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4). World J Surg Oncol (2008) 0.81
Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers. Oncologist (2015) 0.81
Morbidity and mortality of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: national cancer institute, Mexico city, Mexico. ISRN Oncol (2011) 0.81
Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines. Oncotarget (2015) 0.81
Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects. Orphanet J Rare Dis (2014) 0.80
Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients. Gastroenterol Res Pract (2012) 0.80
Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei. Indian J Surg Oncol (2016) 0.80
Preoperative carcinoembryonic antigen level predicts prognosis in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg (2013) 0.79
Surgical treatment of peritoneal carcinomatosis from gastric cancer. Int J Surg Oncol (2012) 0.79
Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases. Indian J Surg Oncol (2016) 0.78
Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol (2014) 0.77
Experience after 100 patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Gastroenterol (2012) 0.77
Repeat Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancy and Peritoneal Carcinomatosis. World J Surg (2015) 0.77
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer. World J Gastroenterol (2016) 0.77
Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters. Am J Cancer Res (2014) 0.77
Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei. Ann Surg Oncol (2012) 0.77
Quality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo procedures. Int J Surg Oncol (2013) 0.76
Peritoneal carcinomatosis of gastrointestinal tumors: where are we now? World J Gastroenterol (2014) 0.76
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. J Transl Med (2016) 0.76
Carbohydrate antigen 19-9 (CA 19-9) is an independent prognostic indicator in pseudomyxoma peritonei post cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Gastrointest Oncol (2013) 0.76
Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol (2016) 0.76
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. J Gastrointest Oncol (2016) 0.76
A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Mol Clin Oncol (2016) 0.75
Drug Sensitivity Testing in Cytoreductive Surgery and Intraperitoneal Chemotherapy of Pseudomyxoma Peritonei. Ann Surg Oncol (2015) 0.75
Pseudomyxoma peritonei. Indian J Surg (2010) 0.75
Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells. Am J Cancer Res (2016) 0.75
Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix. Int Surg (2015) 0.75
A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix. Ann Surg Oncol (2015) 0.75
Retrospective study of nonmucinous appendiceal adenocarcinomas: role of systemic chemotherapy and cytoreductive surgery. BMC Cancer (2017) 0.75
Different medical expenses incurred by appendiceal cystadenoma in China: Report of three cases. Oncol Lett (2013) 0.75
Evolution of management in peritoneal surface malignancies. Ulus Cerrahi Derg (2015) 0.75
Cytoreductive Surgery and HIPEC in the Baltic States: An International Scientific Workshop with Live Surgery. Viszeralmedizin (2014) 0.75
Incidentally discovered low-grade appendiceal mucinous neoplasm: a precursor to pseudomyxoma peritonei. Clin Case Rep (2016) 0.75
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. Indian J Surg Oncol (2015) 0.75
Perforated mucinous cystadenoma of the vermiform appendix: an overview in reasoning clinical decisions. BMJ Case Rep (2011) 0.75
Interstitial pneumonitis following intrapleural chemotherapy. World J Surg Oncol (2009) 0.75
The appropriate management of an appendiceal mucocele. BMJ Case Rep (2015) 0.75
A critical analysis of the cytoreductive surgery with hyperthermic intraperitoneal chemotherapy combo in the clinical management of advanced gastric cancer: an effective multimodality approach with scope for improvement. Transl Gastroenterol Hepatol (2016) 0.75
The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Indian J Surg Oncol (2016) 0.75
Ovarian preservation with subcutaneous transposition in the setting of cytoreductive surgery. Int J Surg Case Rep (2013) 0.75
Application of advanced multimodality care to pseudomyxoma peritonei patient: report of first patient treated at a tertiary center. Indian J Surg Oncol (2010) 0.75
Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy for Management of Peritoneal Sarcomatosis: A Preliminary Single-Center Experience from Saudi Arabia. Gastroenterol Res Pract (2016) 0.75
Validation and use of microdialysis for determination of pharmacokinetic properties of the chemotherapeutic agent mitomycin C - an experimental study. BMC Cancer (2010) 0.75
Large mucinous neoplasm of the appendix mimicking adnexal mass in a postmenopausal woman. Int J Surg Case Rep (2014) 0.75
Debulking surgery and hyperthermic intraperitoneal chemotherapy in the management of a recurrent aggressive uterine myxoid leiomyosarcoma with peritoneal dissemination. Gynecol Oncol Rep (2015) 0.75
Pregnancy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei. Case Rep Surg (2014) 0.75
Unusual contents of a scrotal swelling. BMJ Case Rep (2011) 0.75
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. JMIR Res Protoc (2017) 0.75
Appendiceal Mucinous Neoplasms: Diagnosis and Management. Oncologist (2017) 0.75
[Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification]. Pathologe (2012) 0.75
Giant mucinous adenocarcinoma of the appendix: a case report. J Med Case Rep (2017) 0.75
Pseudomyxoma peritonei masquerading as ascites secondary to alcoholic cirrhosis. Dig Dis Sci (2009) 0.75
Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer. J Surg Oncol (2017) 0.75
The importance of gender in patients with peritoneal metastases of appendiceal origin treated by cytoreduction and intraperitoneal chemotherapy: an analysis of 257 consecutive patients from an Australian centre. J Cancer Res Clin Oncol (2014) 0.75